Health Care Rounds

In today’s Our Take read-in, we discuss hospital market concentrations and their association with DOJ investigations and inpatient prices. To sign up for the weekly email brief, click here. Other briefs include: Novo Nordisk announced that Rybelsus has been approved by the FDA for the treatment of type 2 diabetes. NUW Medicine, MultiCare Health System, and LifePoint Health have partnered to form a clinically integrated network known as Embright. Sanofi and Abbott are collaborating to integrate their diabetes-related technologies. Blue Shield of California is testing rideQ, a ride-share program launched by the Blue Cross Blue Shield Institute last year, in the Sacramento area. Tennessee has proposed switching its Medicaid funding to a block grant. About Darwin Research Group Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s clie